Icecure Medical Q2 2024 GAAP EPS $(0.06) Beats $(0.07) Estimate, Sales $1.01M Beat $925.50K Estimate

Icecure Medical (NASDAQ: ICCM) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.07) by 14.29 percent. The company reported quarterly sales of $1.01 million which beat the analyst consensus estimate of $925.50 thousand by 9.24 percent. This is a 7.90 percent increase over sales of $937.00 thousand the same period last year.